Blog

ESMO recommendations released to provide a roadmap to facilitate the implementation of MTBs in clinical practice

ESMO/LinkedIn

Apr 8, 2025, 18:01

ESMO recommendations released to provide a roadmap to facilitate the implementation of MTBs in clinical practice

ESMO (European Society for Medical Oncology) shared a post on LinkedIn:

“New ESMO recommendations released to provide a roadmap to facilitate the implementation of molecular tumour boards (MTBs) in clinical practice.

The recommendations published in Annals of Oncology provide a structured framework to:

Define core MTB composition
Establish structured workflows for case selection, data integration & follow-up
Set documentation and reporting standards
Introduce quality indicators to assess MTB performance

These are some of the key areas to be addressed to foster consistent and effective MTB operations across diverse healthcare environments and to optimise precision oncology.

Read the ESMO Daily Reporter article.”

More posts featuring ESMO.

Annals of Oncology cancer ESMO ESMO Daily Reporter ESMO Recommendations European Society for Medical Oncology molecular tumour boards MTBs OncoDaily Oncology

Penn Medicine: Cancer Center Near Me

Elevating Childhood Cancer and Catastrophic Diseases in the Global NCD Agenda: Joint Call to Action

Oliver Bogler Announced the Launch of the NanCI AI Webapp for Scientific Literature and Networking

Joe Biden Diagnosed with Aggressive Metastatic Prostate Cancer at Age 82

DESTINY-Breast06 Trial Updates at ESMO Breast 2025 Confirms T-DXd Efficacy in HER2-Low and Ultralow Metastatic Breast Cancer